[1]
2017. Severe injection site reactions after subcutaneous administration of Sayana®: a retrospective, post-marketing analysis of WHO and Swiss spontaneous pharmacovigilance reports. Swiss Medical Weekly. 147, 1920 (May 2017), w14432. DOI:https://doi.org/10.4414/smw.2017.14432.